APA (7th ed.) Citation

Katsuta, E., Yan, L., Takeshita, T., McDonald, K., Dasgupta, S., Opyrchal, M., & Takabe, K. (2019). High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer.

Chicago Style (17th ed.) Citation

Katsuta, Eriko, Li Yan, Takashi Takeshita, Kerry-Ann McDonald, Subhamoy Dasgupta, Mateusz Opyrchal, and Kazuaki Takabe. High MYC MRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer. 2019.

MLA (9th ed.) Citation

Katsuta, Eriko, et al. High MYC MRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer. 2019.